Common Protocol: BPC-157: 250500 mcg daily, subcutaneous near injury or systemic TB500: 25 mg per week, split into 23 injections Cycle: 46 weeks, followed by reassessment 2
Is it an approved medication
Is GHK-Cu Naturally Occurring in the Body
It does not carry the dramatic cautions of, say, high-dose vitamin C, which requires G6PD screening
Room temperature exposure Most compounded tirzepatide can tolerate room temperature (up to 77 to 86 degrees Fahrenheit or 25 to 30 degrees Celsius) for limited periods, typically up to 21 days according to many pharmacy guidelines
Patients on Epithalon consistently report this as one of the earliest changes they notice, typically within the first two to three weeks of a protocol